CGCI: HIV+ Tumor Molecular Characterization Project (HTMCP) – Diffuse Large B-cell Lymphoma (DLBCL)
The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All data from these projects is available at the NCI Genomic Data Commons. CGCI is characterized a number of HIV-associated tumors (including DLBCL, lung and cervical cancers). As part of CGCI, this project was a joint effort of the Office of Cancer Genomics (OCG) and the Office of HIV and AIDS Malignancy (OHAM). Its goals were to characterize HIV-associated cancers (obtained from HIV-infected patients) and compare them to the same types of... (for more see dbGaP study page.)